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Cholesterol (CHOL), free fatty acids (FFA) and nine classes of ceramides (CER1–CER9) form the main constituents of the intercellular
lipid lamellae in stratum corneum (SC), which regulate the skin barrier function. Both the presence of a unique 13-nm lamellar phase, of
which the formation depends on the presence of CER1, and its dense lateral packing are characteristic for the SC lipid organisation. The
present study focuses on the lipid organisation in mixtures prepared with CHOL, FFA and a limited number of synthetic CER, namely CER1,
CER3 and bovine brain CER type IV (SCERIV). The main objective is to determine the optimal molar ratio of CER3 to SCERIV for the
formation of the 13-nm lamellar phase. CER3 contains a uniform acyl chain length, whereas SCERIV contains fatty acids with varying chain
lengths. Using small angle X-ray diffraction (SAXD), it is demonstrated that the CER3 to SCERIV ratio affects the formation of the 13-nm
lamellar phase and that the optimal ratio depends on the presence of FFA. Furthermore, the formation of the 13-nm lamellar phase is not very
sensitive to variations in the total CER level, which is similar to the in vivo situation.
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1. Introduction detected in human SC [1–4], which are classified as CER1The barrier properties of mammalian skin can be ascribed
to the unique composition and structure of its most apical
layer, the stratum corneum (SC). The SC consists of flat
corneocytes, embedded in an intercellular matrix of lipids.
As these lipid domains form the only continuous structure in
the SC, they are considered to play a crucial role in the
maintenance of the skin barrier. Therefore, detailed infor-
mation on the structure and organisation of the SC lipids is
essential for a better understanding of the skin barrier
function.
The main constituents of the intercellular lipid matrix are
ceramides (CER), cholesterol (CHOL) and long-chain free
fatty acids (FFA). Nine different extractable CER have been0005-2736/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: bouwstra@chem.leidenuniv.nl (J.A. Bouwstra).to CER9. The CER can be subdivided into three main
groups, based on the nature of their head group architecture
(sphingosine (S), phytosphingosine (P) or 6-hydroxysphin-
gosine (H)). Through an amide bonding, long-chain non-
hydroxy (N) or a-hydroxy (A) fatty acids with varying acyl
chain lengths are chemically linked to the sphingosine
bases. CER1 (EOS), CER4 (EOH) and CER9 (EOP) are
unique in structure as they contain linoleic acid linked to an
N-hydroxy fatty acid (EO) with a chain length of 30 to 32
carbon atoms. The molecular structures of the CER together
with the two nomenclatures are illustrated in Fig. 1A.
X-ray diffraction studies on native SC have demonstrated
that the SC lipids are organised in two coexisting crystalline
lamellar phases: the short periodicity phase (SPP) with a
periodicity of approximately 6 nm and the long periodicity
phase (LPP) with a periodicity of approximately 13 nm [5–
7]. The 13-nm lamellar phase and its predominantly ortho-
rhombic lipid packing are considered to be crucial for the skin
Fig. 1. The molecular structures of the CER present in human SC (A) and the molecular structures of the synthetic CER used in the study (B). The acyl chain
lengths of CER1(C30) and CER3(C24) are very well defined, whereas bovine brain CER type IV (SCERIV) shows a distribution in chain lengths with C18
and C24 as the most abundantly present.
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prepared with isolated pig or human CER, CHOL and FFA
revealed that the lipid organisation in these mixtures is similar
to that observed in native SC. The main advantage of these
SC lipid models is the possibility to selectively exclude
particular lipid classes from the mixtures, which is not
possible with SC. Therefore, these studies greatly contributed
to our present knowledge on the role of individual SC lipid
classes in the SC lipid organisation. Interestingly, the forma-
tion of the characteristic LPP depends on the presence of
CHOL and specific CER, in particular CER1, whereas FFA
are required for the crystalline (orthorhombic) character of
the lateral lipid packing [8–11].
The use of synthetic lipids can overcome problems
related to isolated SC lipids, such as variability of the native
tissue and the laborious isolation and separation of the SClipids. In a previous study it was shown for the first time that
the SC lipid phase behaviour can already be reproduced to a
high extent with a synthetic lipid mixture consisting of only
three synthetic CER [12]. In that study a fixed CER
composition was used, namely CER1, CER3 and bovine
brain CER type IV (referred to as SCERIV) at a molar ratio
of 1:7:2. In synthetic CER1 and CER3 a fatty acid with a
well-defined acyl chain length is bound to the sphingoid
backbone, whereas in SCERIV fatty acids with varying acyl
chain lengths are present (Fig. 1 and Table 1). Both an
appropriately chosen equilibration temperature during the
sample preparation and the presence of FFA in the mixture
are crucial to achieve a similar lipid organisation as found in
native SC [12]. In spite of great similarities in lipid phase
behaviour between mixtures prepared with natural CER
(natCER) and synthetic CER (synthCER), some differences
Table 1
a-Hydroxy acyl profile in two batches of SCERIV given as percentages of
total a-hydroxy acids
Acyl chain length
a-hydroxy fatty acid
Batch 1
(%)
Batch 2
(%)
C18 18.0 22.2
C20 1.7 0.5
C22 8.0 7.9
C23 11.1 10.6
C24 44.0 41.8
C25 11.3 11.5
C26 5.9 5.5
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presence of either one or two additional phases in mixtures
prepared with synthetic lipids. These additional phases, with
repeat distances of respectively 3.7 and 4.3 nm, can be
ascribed to the presence of crystalline CER3 in a V-shaped
conformation [13–15].
In the study presented in this paper, we further optimised
the composition of the synthetic lipid mixtures to accom-
plish higher resemblance to the SC lipid organisation. To
diminish the formation of the additional crystalline phases,
which are not present in native SC, the amount of CER3 in
the mixture was gradually reduced in favour of SCERIV.
The main objective of the present study was to establish the
optimal molar ratio of CER3 to SCERIV for the formation
of the characteristic LPP and to determine the sensitivity of
the lipid organisation to this ratio. In addition, the sensitivity
of the lipid organisation to changes in the total synthCER
level was studied. This was performed by varying the
composition of the CHOL/synthCER/FFA mixture over a
wide range of molar ratios, thereby maintaining the CHOL/
FFA ratio constant.2. Materials and methods
2.1. Synthetic lipids used in the study
Palmitic acid, stearic acid, arachidic acid, behenic acid,
tricosanoic acid, lignoceric acid, cerotic acid, cholesterol
and bovine brain ceramide type IV were purchased from
Sigma-Aldrich Chemie (Schnelldorf, Germany).N-(30-Lino-
leoyloxy-triacontanoyl)-sphingosine (synthetic ceramide
1(C30)-linoleate) was a gift from Beiersdorf AG (Hamburg,
Germany). N-Tetracosanoyl-phytosphingosine (synthetic
ceramide 3 (C24)) was generously provided by Cosmoferm
B.V. (Delft, the Netherlands). Fig. 1B shows the ceramides
used in this study. All organic solvents used were of analytical
grade and manufactured by Labscan (Dublin, Ireland).
2.2. Preparation and analysis of fatty acid methyl esters
(FAMEs)
To establish the fatty acid profile in SCERIV, the lipid
was dissolved in 100-Al toluene and transmethylated in 1-mlboron trichloride in methanol (10%) using microwave
irradiation, which was carried out at the lowest power
setting (85 W) for 4 h. FAMEs dissolved in hexane and
purified on a silica gel column were separated and analyzed
on a Vega GC 6000 gas chromatograph (Carlo Erba Instru-
ments, Italy) using capillary column CP Wax 52 (Chrom-
pack, The Netherlands). An initial temperature of 80 jC was
increased to 160 jC with a rate of 40 jC/min followed by a
4 jC/min increase to 250 jC that was maintained until all
peaks had eluted. The peaks were identified by comparison
with FAME standards (Sigma-Aldrich Chemie). Integration
of peak areas and calculation of relative percentages were
performed by Baseline 810 integrator. Heptadecanoic acid
was used as an internal standard.
2.3. Preparation of the lipid mixtures
For the preparation of all CHOL/synthCER and CHOL/
synthCER/FFA mixtures, a synthetic CER mixture was used
that consisted of CER1, CER3 and SCERIV at a molar ratio
ranging from 1:1:8 to 1:8:1. For the preparation of the
CHOL/synthCER/FFA mixtures, the following fatty acid
mixture was used: C16:0, C18:0, C20:0, C22:0, C23:0,
C24:0 and C26:0 at molar ratios of 1.3, 3.3, 6.7, 41.7,
5.4, 36.8 and 4.7, respectively. This ratio is similar to that
found in native SC [16]. Appropriate amounts of individual
lipids dissolved in chloroform/methanol (2:1) were com-
bined to yield lipid mixtures of approximately 1.5 mg dry
weight at the desired composition with a total lipid concen-
tration of 7 mg/ml. A Camag Linomat IV was used to apply
the lipid mixtures onto mica. This was done at a rate of 4.3
Al/min under a continuous nitrogen flow. The samples were
equilibrated for 10 min at the appropriate elevated temper-
ature that varied from 70 to 90 jC and subsequently
hydrated with an acetate buffer of pH 5.0. Finally, the
samples were homogenised by 10 successive freeze–thaw-
ing cycles between  20 jC and room temperature, during
which the samples were stored under gaseous argon.
2.4. Small angle X-ray diffraction (SAXD)
All measurements were performed at the European
Synchrotron Radiation Facility (ESRF, Grenoble) using
station BM26B. A more detailed description of this beam-
line has been given elsewhere [17]. The X-ray wavelength
and the sample-to-detector distance were 1.24A˚ and 1.7 m,
respectively. Diffraction data were collected on a two-
dimensional multiwire gas-filled area detector. The spatial
calibration of this detector was performed using silver
behenate. The samples were mounted in a specially
designed sample holder with mica windows. All measure-
ments were recorded at room temperature for a period of
10 min.
SAXD provides information about the larger structural
units in the sample, namely the repeat distance of a lamellar
phase. The scattering intensity I (in arbitrary units) was
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reciprocal nm). The latter is defined as q=(4psinh)/k, in
which h is the scattering angle and k is the wavelength.
From the positions of a series of equidistant peaks ( qn), the
periodicity, or d-spacing, of a lamellar phase was calculated
using the equation qn = 2np/d, n being the order number of
the diffraction peak.3. Results
3.1. Fatty acid profile in SCERIV
To assess the fatty acid profile in SCERIV, two batches
of SCERIV were subjected to transmethylation with boron
trichloride in methanol followed by purification of the
FAME by column chromatography. In this way, fractions
containing methyl esters of a-hydroxy fatty acids were
collected and subsequently analysed by gas chromatogra-
phy. The results of the FAME analysis summarised in Table
1 show low batch-to-batch variation in the composition and
the relative amounts of the various a-hydroxy fatty acids.
All lipid mixtures used in our studies were prepared with
batch 2. There, the most abundantly fatty acids were C18
(22%) and C24 (42%).
3.2. Mixtures prepared with equimolar ratios of CHOL and
syntCER
The main objective of these studies is to determine the
optimal molar ratio between CER3 and SCERIV for the
formation of the LPP. All syntCER mixtures contained the
same relative amount of CER1 (10%m/m), as earlier studies
revealed that this amount is sufficient for the formation of
the LPP. The relative content of CER3 and SCERIV in
CER1/CER3/SCERIV mixtures was varied between a mo-
lar ratio of 1:1:8 and 1:8:1. During preparation, the dry lipid
mixtures were equilibrated at either 80 or 90 jC. These
temperatures were chosen, as use of a higher temperature
results in melting of the CER1/CER3/SCERIV mixture
with a molar ratio of 1:1:8, while use of a lower equilibra-
tion temperature results in reduced LPP formation [12]. As
no clear differences in the formation of the lamellar phases
have been observed between the lipid mixtures prepared at
80 or 90 jC, only the results of the mixtures equilibrated at
90 jC will be presented.
The diffraction pattern of the equimolar CHOL/syn-
thCER mixture in which the CER fraction was prepared
by mixing CER1/CER3/SCERIV to achieve a molar ratio of
1:1:8 is shown in Fig. 2A. A lamellar phase with a repeat
distance of 5.5 nm (SPP) is indicated by the presence of a
strong reflection at q = 1.14 nm 1 and two weak reflections
at 2.29 and 3.43 nm 1. The diffraction pattern further
depicts three weak diffraction peaks at 0.48, 0.97 and 1.45
nm 1, respectively. Taking into account the diffraction
patterns depicted in Figs. 2 and 3 (see below), it isconceivable to ascribe these reflections to the 1st, 2nd and
3rd order maxima of the LPP with a repeat distance of
approximately 13 nm. In addition, crystalline CHOL in
separate domains is present, deduced from the sharp peaks
at 1.87 and 3.74 nm 1.
A rise in the CER3 content at the expense of SCERIV to
reach a CER1/CER3/SCERIV molar ratio of 1:3:6 was
accompanied by a slight increase in peak width (Fig. 2A).
This results in a partial overlap of the peaks located at 0.98
and 1.16 nm 1. In addition, a new structure with a repeat
distance of 3.7 nm is present in the mixture, suggested by
two reflections at respectively 1.69 and 3.40 nm 1. This
phase can be ascribed to crystalline CER3 in a V-shaped
structure [13–15].
Fig 2B shows the diffraction pattern of the CHOL/
synthCER mixture prepared at a 1:5:4 ratio of CER1,
CER3 and SCERIV. Compared to the diffraction patterns
obtained at lower CER3 content (1:1:8 and 1:3:6), the peak
intensities of the LPP are considerably increased compared
to the reflections attributed to the SPP, indicating that the
formation of the LPP is promoted at increased CER3
content. Similarly as in the 1:3:6 mixture, only one reflec-
tion of the SPP can be detected. In addition, crystalline
CER3 and crystalline CHOL are present.
A further rise in CER3 content to a CER1/CER3/
SCERIV ratio of 1:7:2 results in the diffraction pattern
illustrated in Fig. 2C. Obviously, the reflection at q = 1.71
nm 1 is the most prominent peak. This suggests that a
considerable amount of crystalline CER3 phase-separates
into a 3.7-nm phase. The LPP and SPP are still present in
the mixture, but compared to Fig. 2B, the intensities of the
reflections attributed to both phases are weaker than the
peak intensities of CHOL and CER3.
At a CER1/CER3/SCERIV ratio of 1:8:1, a marked
reduction of LPP formation is observed. Only a small lipid
fraction forms a lamellar phase with a periodicity of 12.4
nm, whereas substantial amounts of crystalline CER3 are
present in separate domains.
3.3. Mixtures prepared with equimolar ratios of CHOL,
synthCER and FFA
The lipid organisation of mixtures containing FFA has
also been examined, as FFA represent the third major lipid
species in the SC. In a previous study it was observed that
dry CHOL/synthCER/FFA mixtures melted at a lower
equilibration temperature than CHOL/synthCER mixtures
[11]. The dry lipid mixtures in the present study were
therefore equilibrated at slightly lower temperatures, name-
ly at 70 or 80 jC. As no obvious differences could be
observed in the formation of the lamellar phases between
mixtures equilibrated at 70 or 80 jC, only the results
obtained at an equilibration temperature of 80 jC will be
reported.
The phase behaviour of the CHOL/[CER1/CER3/
SCERIV]/FFA mixture prepared at a molar ratio of
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pattern reveals the presence of a strong reflection at
q = 1.05 nm 1 and two weak reflections at 2.09 and 3.15
nm 1. These peaks are located at positions at which the
2nd, 4th and 6th order diffraction peaks of the LPP should
be expected. However, as no 1st and 3rd order reflections of
the LPP are present, the reflections most likely relate to
another phase with a periodicity of 6.0 nm. In addition, the
SPP with a periodicity of 5.4 nm is present, deduced from
the presence of a shoulder at the right-hand side of the
strong peak (1st order) and a weak reflection at 3.50 nm 1
(3rd order). A small fraction of CHOL phase separates into
crystalline domains, indicated by one weak reflection at
1.87 nm 1.
A rise in CER3 content to reach a CER1/CER3/SCERIV
ratio of 1:3:6 results in a clear appearance of the reflections
attributed to the LPP. At this increased CER3 level, crys-
talline CER3 is present in separate domains as indicated by
the two peaks at 1.71 and 3.43 nm 1. In addition, the SPP
and small amounts of crystalline CHOL are present in the
lipid mixture.
The diffraction pattern of the mixture at a CER1/CER3/
SCERIV molar ratio of 1:5:4 is presented in Fig. 3B. The
increased CER3 level obviously results in increased inten-
sities of the peaks attributed to the LPP compared to those
attributed to the SPP. Five diffraction peaks of the LPP
with a periodicity of 12.0 are present and two reflections
of a 5.4-nm phase (SPP) can be detected. Crystalline
CER3 and crystalline CHOL can also be detected in the
mixture.
A further rise in the CER3 content to a molar ratio of
1:7.2 promotes the formation of the LPP even more. The
presence of the LPP, with a slightly decreased repeat
distance of 11.9 nm, is indicated by six reflections,
whereas the SPP is indicated by two reflections. Weak
reflections designate small amounts of crystalline CHOL,
whereas strong peaks at 1.71 and 3.43 nm 1 indicate thatFig. 2. The effect of the CER3 to SCERIV molar ratio on the phase
behaviour of equimolar CHOL/synthCER mixtures. The inset is a
magnification of the reflections in the q-range between 2 and 4 nm 1.
The Arabic numbers indicate the diffraction orders of the LPP, whereas the
Roman numbers indicate the diffraction orders of the SPP. The letter C
refers to the reflections of crystalline phase of CER3 at 1.71 and 3.42
nm 1. The asterisk (*) indicates the reflections of crystalline CHOL located
at 1.87 and 3.74 nm 1. (A) Diffraction patterns of CHOL/[CER1/CER3/
SCERIV] mixtures at a molar ratio of 1:[0.1:0.1:0.8] and 1:[0.1:0.3:0.6].
The various orders of the LPP are located at q= 0.48 nm 1 (1st), 0.97
nm 1 (2nd) and 1.45 nm 1 (3rd). The various orders of the SPP are located
at q= 1.14 nm 1 (1st), 2.29 nm 1 (2nd) and 3.43 nm 1 (3rd). (B)
Diffraction pattern of 1:[0.1:0.5:0.4] mixture. The various orders of the LPP
are located at q= 0.50 nm 1 (1st), 1.01 nm 1 (2nd) and 1.49 nm 1 (3rd).
The only reflection attributed to the SPP is located at q= 1.16 nm 1 (1st).
(C) Diffraction patterns of 1:[0.1:0.7:0.2] and 1:[0.1:0.8:0.1] mixtures. The
various orders of the LPP are located at q= 0.50 nm 1 (1st), 1.01 nm 1
(2nd) and 1.49 nm 1 (3rd). The only reflection attributed to the SPP is
located at q= 1.14 nm 1 (1st).
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crystalline phase.
The diffraction pattern of the lipid mixture prepared with
a 1:8:1 composition of CER1/CER3/SCERIV is plotted in
Fig. 3C. Compared to the diffraction pattern of the 1:7:2
mixture, the relative intensities of the reflections of both
LPP and SPP do not change significantly. However, the
number of higher order reflections, which can be detected
for both LPP and SPP, is reduced.
3.4. CHOL/synthCER/FFA mixtures with a variation in
synthCER content
In order to determine whether the lipid organisation is
sensitive to the synthCER content, the composition of the
CHOL/synthCER/FFA mixture was varied over a wide
synthCER level, thereby maintaining an equimolar CHOL
to FFA ratio. The synthCER fraction was prepared with a
1:7:2 molar ratio of CER1, CER3 and SCERIV, as this
appeared to be optimal for the formation of the LPP in the
presence of FFA. At a CHOL/synthCER/FFA molar ratio
of 1:2:1 and 1:1.5:1, the majority of the lipids form the
LPP with a repeat distance of 12.0 nm (Fig. 4A). Reducing
the synthCER content to a CHOL/synthCER/FFA ratio of
1:0.75:1 does not affect the formation of the LPP or SPP
dramatically. A further decrease in the synthCER content
to 1:0.5:1 is accompanied by a slight reduction in the
fraction of lipids forming the LPP (Fig. 4B). These
findings indicate that the formation of the lamellar phases
is not very sensitive towards substantial changes in the
relative synthCER content.
Concerning phase-separated CHOL, we observe that an
increased relative amount of CHOL results in increased
intensities of the reflections attributed to phase-separated
CHOL, whereas almost no phase-separated CHOL is pres-
ent at a CHOL/synthCER/FFA ratio of 1:2:1. This is inFig. 3. The effect of the CER3 to SCERIV molar ratio on the phase
behaviour of equimolar CHOL/synthCER/FFA mixtures. The inset is a
magnification of the reflections in the q-range between 2 and 4 nm 1.
The Arabic numbers indicate the diffraction orders of the LPP, whereas
the Roman numbers indicate the diffraction orders of the SPP. The letter
C refers to the reflections of crystalline phase of CER3 at 1.71 and 3.42
nm 1. The asterisk (*) indicates the reflections of crystalline CHOL
located at 1.87 and 3.74 nm 1. (A) Diffraction patterns of CHOL/[CER1/
CER3/SCERIV]/FFA mixtures at a molar ratio of 1:[0.1:0.1:0.8]:1 and
1:[0.1:0.3:0.6]:1. The various orders of the LPP in the latter mixture are
located at q= 0.52 nm 1 (1st), 1.03 nm 1 (2nd), 1.52 nm 1 (3rd) and
2.06 nm 1 (4th). The various orders of the SPP are located at q= 1.16
nm 1 (1st), 2.31 nm 1 (2nd) and 3.48 nm 1 (3rd). (B) Diffraction
pattern of 1:[0.1:0.5:0.4]:1 mixture. The various orders of the LPP are
located at q= 0.52 nm 1 (1st), 1.05 nm 1 (2nd), 1.56 nm 1 (3rd), 2.11
nm 1 (4th) and 3.64 nm 1 (7th). The various reflections attributed to the
SPP are located at q= 1.16 nm 1 (1st) and 2.33 nm 1 (2nd). (C)
Diffraction patterns of 1:[0.1:0.7:0.2]:1 and 1:[0.1:0.8:0.1]:1 mixture. The
various orders of the LPP are located at q= 0.52 nm 1 (1st), 1.05 nm 1
(2nd), 1.58 nm 1 (3rd), 2.11 nm 1 (4th), 3.12 nm 1 (6th) and 3.65
nm 1 (7th). The various orders of the SPP are located at q= 1.17 nm 1
(1st) and 2.34 nm 1 (2nd).
Fig. 4. Effect of changing the CER molar ratio, thereby maintaining an
equimolar CHOL to FFA ratio. The inset is a magnification of the
reflections in the q-range between 2 and 4 nm 1. The Arabic numbers
indicate the diffraction orders of the LPP, whereas the Roman numbers
indicate the diffraction orders of the SPP. The letter C refers to the
reflections of crystalline phase of CER3 at 1.71 and 3.42 nm 1. The
asterisk (*) indicates the reflections of crystalline CHOL located at 1.87 and
3.74 nm 1. (A) Diffraction patterns of CHOL/synthCER/FFA mixtures at a
molar ratio of 1:2:1 and 1:1.5:1. The various orders of the LPP are located
at q= 0.52 nm 1 (1st), 1.03 nm 1 (2nd), 1.56 nm 1 (3rd), 2.08 nm 1
(4th), 3.09 nm 1 (6th) and 3.60 nm 1 (7th). The various orders of the SPP
are located at q= 1.16 nm 1 (1st) and 2.32 nm 1 (2nd). (B) Diffraction
patterns of 1:0.75:1 and 1:0.5:1 mixtures. The various orders of the LPP are
located at q= 0.49 nm 1 (1st), 0.99 nm 1 (2nd), 1.48 nm 1 (3rd), 1.99
nm 1 (4th) and 3.49 nm 1 (7th). The various reflections attributed to the
SPP are located at q= 1.17 nm 1 (1st) and 2.34 nm 1 (2nd).
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do not observe phase separation of CHOL at a CHOL/CER/
FFA ratio of 1:2:1.4. Discussion
Previous studies revealed that mixtures prepared with
CHOL, FFA and CER isolated from pig or human SC mixed
in a proper molar ratio mimic the SC lipid phase behaviour
very closely [8–10]. These observations offered an attrac-
tive opportunity to study the role these lipids play in the SC
lipid organisation. Furthermore, due to its lipophilic nature,
CER1 could be separated from the remaining CER and
isolated in sufficient large quantities. This offered the
possibility to examine in detail the role CER1 plays in SC
lipid organisation. As each subclass of natural CER consists
of ceramides with varying acyl chain lengths [4], the study
on the effect of the variation in acyl chain length on the SC
lipid phase behavior is difficult to perform with natCER.
Therefore, the use of synthCER with a well-defined acyl
chain length and head group architecture may overcome this
problem. In a previous study, a first step has been made to
investigate this by selecting a synthCER mixture consisting
of CER1 and either synthetic CER3 with a uniform acyl
chain length of 24 carbon atoms or semisynthetic SCERIV
containing fatty acids with varying acyl chain lengths. We
demonstrated that equimolar CHOL/synthCER mixtures
prepared with CER1 and SCERIV do not form the LPP,
while in mixtures prepared with synthetic CER1 and CER3
a small lipid fraction forms a 11.6-nm lamellar phase [13].
In a very recent study, we studied the phase behaviour of
CHOL/synthCER and CHOL/synthCER/FFA mixtures pre-
pared with a 1:7:2 molar ratio of CER1, CER3 and SCERIV
[12]. The results of that study reveal that the LPP is formed
in the lipid mixtures, provided that an optimal equilibration
temperature is used during the preparation procedure. The
phase behaviour of equimolar CHOL/synthCER/FFA mix-
tures equilibrated at 80 jC resembled to a high extent the
lamellar and lateral lipid organisation found in native human
or pig SC. However, the presence of one or two additional
crystalline phases was noticed, which are not present in SC
and can be ascribed to crystalline CER3. Furthermore, the
relative intensities of the various diffraction peaks attributed
to the LPP were slightly different from those observed with
mixtures prepared with isolated CER.
In the present study, the CER3 to SCERIV ratio in the
synthCER fraction was varied to enhance the formation of
the LPP and to reduce the formation of additional crystalline
phases. The results clearly demonstrate that in the absence
of FFA, a CER1/CER3/SCERIV molar ratio of 1:5:4 is
optimal for the formation of the LPP. In the presence of
FFA, the optimal CER composition shifts to a CER1/CER3/
SCERIV molar ratio of 1:7:2. Furthermore, the peak width
at half maximum of a number of reflections is much smaller
in the diffraction patterns of the mixtures prepared with FFA
compared to those of the CHOL/synthCER mixtures. This
indicates that FFA increase the ordering of the lipid orga-
nisation. This has also been observed in our previous study
[12]. Although the optimal synthCER compositions could
be selected for the formation of the LPP, it is obvious from
M.W. de Jager et al. / Biochimica et Biophysica Acta 1684 (2004) 132–140 139our data that the lipid organisation is not extremely sensitive
towards variations in relative amounts of CER3 and
SCERIV in the lipid mixture. This is similar to the obser-
vations made with equimolar CHOL/natCER mixtures,
which were remarkably insensitive towards changes in the
natCER composition [19]. Only a strong reduction in the
level of natCER1 decreased the formation of the LPP.
In equimolar CHOL/synthCER/FFA mixtures, the inten-
sities of the reflections attributed to crystalline CHOL are
much weaker than in the CHOL/synthCER mixtures. This
indicates that FFA increase the solubility of CHOL into the
lamellar phases, which is consistent with observations made
with mixtures based on natCER [8–10,18]. Furthermore,
the diffraction patterns of the synthCER mixtures do not
show reflections ascribed to FFA in a separate phase (Figs. 3
and 4). This suggests that FFA are completely intercalated in
the lamellar phases and their presence is required for the
formation of an orthorhombic sublattice within the lipid
lamellae [8,10,12].
The synthetic lipid mixtures also contain an additional
3.7-nm phase, which is not present in native SC and can be
ascribed to crystalline CER3. A rise in SCERIV content at
the expense of CER3 increases the acyl chain length
variation in the synthCER mixture (Table 1) and reduces
the formation of phase-separated crystalline CER3. For a
complete elimination of the 3.7-nm phase, the relative
CER3 level should be below 3 (CER1/CER3/SCERIV
molar ratio of 1:3:6). However, this increased SCERIV
level is accompanied by a reduction in LPP formation, as is
clearly demonstrated by the results of the present study.
Partial replacement of CER3 by CER4 with known acyl
chain lengths (e.g. C18 and C24 at a ratio of 1:2, mimicking
the distribution in the SCERIV batch used in the present
study) might offer a possibility to reduce the amount of
phase-separated CER3.
The present study further demonstrates that a reduction in
LPP formation is only observed when the total synthCER
content is reduced to a CHOL/synthCER/FFA molar ratio of
1:0.5:1. This low sensitivity towards changes in the CHOL/
synthCER/FFA molar ratio is in agreement with previous
studies performed with mixtures prepared with natCER
[8,10]. When extrapolating these findings to the in vivo
situation, one can state that small variations in the molar
ratios of the SC lipids will not lead to a substantial change in
lipid organisation. Most phase behaviour studies performed
with either isolated or synthetic lipids have been performed
with equimolar lipid mixtures. A recent study on tape-
stripped SC shows that CHOL, CER and FFA are present
at a molar ratio of approximately 1:1.5:1 [20], rather than
the generally assumed equimolar ratio. However, inspection
of literature data shows that there is a high interindividual
variability in SC lipid composition. This high variability
together with the finding that the LPP has been detected in
all SC samples studied so far can be ascribed to the fact that
the LPP is formed in CHOL/CER/FFA mixtures even when
the composition varies over a wide molar range.In conclusion, the results of the present study and
previous studies demonstrate that one can generate lipid
mixtures with limited number of synthCER that mimic
closely the lipid phase behaviour of native SC. The presence
of FFA, the temperature used for equilibrating the mixtures
and the CER3 to SCERIV ratio are important parameters for
a proper lipid organisation.Acknowledgements
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